CRT 2025

Spotlight

Hot Topics in Heart Failure

Mavacamten for Patients who have Failed Prior Advanced Therapy for LV Outflow Obstruction | After Alcohol Ablation, Surgery, Disopyramide and for LVOT Obstruction After AVR and TAVR

Speaker(s)

• 

  Mark V. Sherrid, MD

  Director, Hypertrophic Cardiomyopathy Program
  New York University Health
  New York City, New York, United States

  Disclosure information not submitted.